Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.32−0.10 (-7.04%)
Close on Nov 12, 2026Market cap $83.70MP/E –Yield –
Equillium enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Equillium's enterprise value was $32.88M on Nov 11, 2026, against $21.63M a year earlier. Over the last 5 years it ranged from -$40.64M to $141.00M, with a median of $11.63M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $32.88M | -46.0% |
| 2025 | Dec 31, 2025 | $60.93M | +9978.8% |
| 2024 | Dec 31, 2024 | $604.53K | – |
| 2023 | Dec 29, 2023 | -$20.91M | -1032.1% |
| 2022 | Dec 30, 2022 | $2.24M | -92.6% |
| 2021 | Dec 31, 2021 | $30.20M | -41.5% |
| 2020 | Dec 31, 2020 | $51.65M | +740.2% |
| 2019 | Dec 31, 2019 | $6.15M | -92.8% |
| 2018 | Dec 31, 2018 | $85.84M | – |
See a number that looks wrong?